Loading clinical trials...
Loading clinical trials...
A Phase 2 Trial of Radium Ra 223 Dichloride in Combination With Androgen Deprivation Therapy and Stereotactic Body Radiation Therapy for Patients With Oligometastatic Castration Sensitive Prostate Cancer
Conditions
Interventions
Leuprolide Acetate
Goserelin Acetate
+4 more
Locations
1
United States
City of Hope Medical Center
Duarte, California, United States
Start Date
August 29, 2018
Primary Completion Date
February 4, 2026
Completion Date
February 4, 2026
Last Updated
May 2, 2025
NCT05691465
NCT06205316
NCT06470750
NCT05053152
NCT05050084
NCT04134260
Lead Sponsor
City of Hope Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions